HSBC raises returns outlook as profits drop less than expected

HSBC reported 2025 pre-tax profit down 7.4% to $29.9bn but ahead of consensus, with underlying pre-tax profit up ~7% to $36.6bn; revenue rose ~4% to $68.3bn, beating estimates, as net interest income increased 6% to $34.8bn and NIM edged up to 1.59%. Headline results were hit by $4.9bn of notable items (including $2.1bn BoCom losses, $1.5bn from a French loan-book sale, $1.4bn of legal provisions and $1.0bn restructuring costs); CET1 was 14.9% and credit impairments were $3.9bn. Management raised medium-term targets—seeking a 17% RoTE (ex-notable items) for 2026–28, expects at least $45bn of banking NII in 2026, and will maintain a c.50% payout ratio (total 2025 dividend $0.75/share).

Analysis

Market structure: HSBC’s beat and upgraded 2026 NII target ($45bn vs $34.8bn in 2025) reweights winners toward Asia‑focused universal banks and long‑duration NII beneficiaries. Direct beneficiaries: HSBC (HSBA/HSBC) and global banks with large USD/HKD rate exposure; losers: EU/UK retail‑centric banks with weaker NII leverage. Cross‑asset: improved equity sentiment should tighten senior spreads (sovereign/IG carry flows into bank bonds), compress HY spreads in banking, push modest appreciation in HKD/GBP‑pegged positions vs EUR; options vol on HSBC should fall on execution credibility.

Risk assessment: Tail risks include a China shock (further BoCom writedowns >$2–5bn), surprise regulatory fines or a macro credit cycle that pushes credit impairments >$6bn annually, and legal provisions that recur. Short horizon (days–weeks): headline volatility from analyst reactions to notable items; medium (3–12 months): realization of NII guidance and RoTE; long (>12 months): structural capital returns (share buybacks/dividend) hinge on CET1 staying >14.0–14.5% and macro credit. Hidden dependency: guidance assumes stable/higher rates and no material China exposure; if HKD/USD policy or China growth reverses, RoTE target is at risk.

Trade implications: Primary direct play is selective long HSBC equity sized to conviction with defined stop (see actions). Relative value: long HSBC vs short UK retail banks (e.g., BARC.L) to capture shift to Asia NII. Options: use 9–15 month call spreads to monetize a falling IV into catalyst window (Q1–Q2 2026 NII prints). Credit: prefer 3–7yr senior paper if 5yr spread >120–150bps over swaps; avoid AT1 unless pricing >600bps.

Contrarian angles: Consensus may over‑focus on headline profit drop and notable items; underlying RoTE 17% target and CET1 14.9% imply room for buybacks/dividend growth and 12–20% equity upside if execution holds. Overdone reaction: selloffs that ignore NII rehypothecation into RoTE. Risk: misexecution on cost/legal could erase the uplift—set binary stop levels (CET1 <14.0% or NII < $44bn triggers reassessment).

Key Decisions for Investors

• Establish a 2–3% long position in HSBC (HSBA.L / HSBC) sized to portfolio risk within 2 weeks; target 12–18% upside over 6–12 months assuming NII ≥ $45bn and RoTE ≥17%; implement stop‑loss at −8% absolute or if CET1 falls below 14.0% or bank revises NII guidance < $44bn.
• Implement a pair trade: long HSBC (HSBA.L) vs short Barclays (BARC.L) in equal notional sizes for 3–9 months to capture Asia NII tailwind and differential RoTE execution; reduce position if spread between their 3‑month returns compresses to <1.5% annualized.
• Buy a 9–15 month call spread on HSBC (e.g., 15–25% OTM buy call / 30–40% OTM sell call depending on strikes available) to asymmetrically capture upside into H1 2026 earnings and NII prints; allocate <0.5% portfolio capital to the position.
• Deploy capital into HSBC 3–7yr senior bonds if the 5‑year senior spread exceeds 120–150bps over swaps or yields exceed 4.5%; avoid AT1 unless pricing >600bps and only allocate <0.5% to high‑yield subordinated paper.